These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7858606)

  • 21. Catabolic stress induces features of chondrocyte senescence through overexpression of caveolin 1: possible involvement of caveolin 1-induced down-regulation of articular chondrocytes in the pathogenesis of osteoarthritis.
    Dai SM; Shan ZZ; Nakamura H; Masuko-Hongo K; Kato T; Nishioka K; Yudoh K
    Arthritis Rheum; 2006 Mar; 54(3):818-31. PubMed ID: 16508959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene transfer of type 1 interleukin-1 receptor extracellular-domain complementary DNA into rabbit synovial cell line HIG-82 results in cellular blockade of interleukin-1 signal transduction.
    Mehraban F; Kasturi S
    Arthritis Rheum; 1998 Mar; 41(3):515-24. PubMed ID: 9506580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist.
    Smeets RL; Joosten LA; Arntz OJ; Bennink MB; Takahashi N; Carlsen H; Martin MU; van den Berg WB; van de Loo FA
    Arthritis Rheum; 2005 Jul; 52(7):2202-11. PubMed ID: 15986350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of interleukin-8 in PiT-1 expression and CXCR1-mediated inorganic phosphate uptake in chondrocytes.
    Cecil DL; Rose DM; Terkeltaub R; Liu-Bryan R
    Arthritis Rheum; 2005 Jan; 52(1):144-54. PubMed ID: 15641067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Suppression of articular cartilage breakdown in osteoarthritis by interleukin-1 receptor antagonist using ex vivo gene therapy].
    Guo WS; Ma L; Li ZR
    Zhonghua Yi Xue Za Zhi; 2004 May; 84(10):853-6. PubMed ID: 15200893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Collagenase 3 production by human osteoarthritic chondrocytes in response to growth factors and cytokines is a function of the physiologic state of the cells.
    Tardif G; Pelletier JP; Dupuis M; Geng C; Cloutier JM; Martel-Pelletier J
    Arthritis Rheum; 1999 Jun; 42(6):1147-58. PubMed ID: 10366107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-1 receptor accessory protein is an essential component of the IL-1 receptor.
    Cullinan EB; Kwee L; Nunes P; Shuster DJ; Ju G; McIntyre KW; Chizzonite RA; Labow MA
    J Immunol; 1998 Nov; 161(10):5614-20. PubMed ID: 9820540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, reduces the progression of experimental osteoarthritis in guinea pigs.
    Kobayashi T; Notoya K; Naito T; Unno S; Nakamura A; Martel-Pelletier J; Pelletier JP
    Arthritis Rheum; 2005 Feb; 52(2):479-87. PubMed ID: 15692987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal of autocrine and paracrine effects of interleukin 1 (IL-1) in human arthritis by type II IL-1 decoy receptor. Potential for pharmacological intervention.
    Attur MG; Dave M; Cipolletta C; Kang P; Goldring MB; Patel IR; Abramson SB; Amin AR
    J Biol Chem; 2000 Dec; 275(51):40307-15. PubMed ID: 11007768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-like growth factor 1-induced interleukin-1 receptor II overrides the activity of interleukin-1 and controls the homeostasis of the extracellular matrix of cartilage.
    Wang J; Elewaut D; Veys EM; Verbruggen G
    Arthritis Rheum; 2003 May; 48(5):1281-91. PubMed ID: 12746901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes.
    Tetlow LC; Adlam DJ; Woolley DE
    Arthritis Rheum; 2001 Mar; 44(3):585-94. PubMed ID: 11263773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of a low molecular weight isoform of IL-1 receptor antagonist.
    Malyak M; Guthridge JM; Hance KR; Dower SK; Freed JH; Arend WP
    J Immunol; 1998 Aug; 161(4):1997-2003. PubMed ID: 9712072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracellular release of the type I intracellular IL-1 receptor antagonist from human airway epithelial cells: differential effects of IL-4, IL-13, IFN-gamma, and corticosteroids.
    Levine SJ; Wu T; Shelhamer JH
    J Immunol; 1997 Jun; 158(12):5949-57. PubMed ID: 9190949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-1beta induced activation of nuclear factor-kappab can be inhibited by novel pharmacological agents in osteoarthritis.
    Lauder SN; Carty SM; Carpenter CE; Hill RJ; Talamas F; Bondeson J; Brennan P; Williams AS
    Rheumatology (Oxford); 2007 May; 46(5):752-8. PubMed ID: 17218328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catabolic stress induces expression of hypoxia-inducible factor (HIF)-1 alpha in articular chondrocytes: involvement of HIF-1 alpha in the pathogenesis of osteoarthritis.
    Yudoh K; Nakamura H; Masuko-Hongo K; Kato T; Nishioka K
    Arthritis Res Ther; 2005; 7(4):R904-14. PubMed ID: 15987493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteoarthritis gene therapy.
    Evans CH; Gouze JN; Gouze E; Robbins PD; Ghivizzani SC
    Gene Ther; 2004 Feb; 11(4):379-89. PubMed ID: 14724685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders.
    Libra M; Mangano K; Anzaldi M; Quattrocchi C; Donia M; di Marco R; Signorelli S; Scalia G; Zignego AL; de Re V; Mazzarino MC; Nicoletti F
    Oncol Rep; 2006 May; 15(5):1305-8. PubMed ID: 16596202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytokines and inflammation in cartilage degradation.
    Pelletier JP; DiBattista JA; Roughley P; McCollum R; Martel-Pelletier J
    Rheum Dis Clin North Am; 1993 Aug; 19(3):545-68. PubMed ID: 8210574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The interleukin-1 receptor in normal and osteoarthritic human articular chondrocytes. Identification as the type I receptor and analysis of binding kinetics and biologic function.
    Martel-Pelletier J; McCollum R; DiBattista J; Faure MP; Chin JA; Fournier S; Sarfati M; Pelletier JP
    Arthritis Rheum; 1992 May; 35(5):530-40. PubMed ID: 1533521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of human normal and osteoarthritic chondrocyte interleukin-1 receptor by antirheumatic drugs.
    Pelletier JP; McCollum R; DiBattista J; Loose LD; Cloutier JM; Martel-Pelletier J
    Arthritis Rheum; 1993 Nov; 36(11):1517-27. PubMed ID: 8240429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.